(January 29, 2021, 2:12 PM EST) -- WASHINGTON, D.C. — The U.S. Federal Trade Commission on Jan. 25 filed a civil antitrust complaint against Endo Pharmaceuticals Inc., Impax Laboratories LLC and Amneal Pharmaceuticals Inc., alleging that the defendants’ 2017 agreement sought to eliminate competition for the opioid oxymorphone ER....